American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
30.43
+0.50 (1.67%)
At close: Mar 28, 2025, 4:00 PM
29.44
-0.99 (-3.26%)
After-hours: Mar 28, 2025, 8:00 PM EDT
American Healthcare REIT Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for American Healthcare REIT stock have an average target of 32.33, with a low estimate of 28 and a high estimate of 37. The average target predicts an increase of 6.24% from the current stock price of 30.43.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for American Healthcare REIT stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $36 → $37 | Buy | Maintains | $36 → $37 | +21.59% | Mar 25, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $34 | Buy | Reiterates | $34 | +11.73% | Mar 19, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +15.02% | Mar 4, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $27 → $29 | Buy | Maintains | $27 → $29 | -4.70% | Dec 30, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $28 → $30 | Buy | Maintains | $28 → $30 | -1.41% | Nov 18, 2024 |
Financial Forecast
Revenue This Year
2.26B
from 2.06B
Increased by 9.56%
Revenue Next Year
2.39B
from 2.26B
Increased by 5.48%
EPS This Year
0.39
from -0.29
EPS Next Year
0.64
from 0.39
Increased by 64.94%
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 2.6B | 2.7B |
| Avg | 2.3B | 2.4B |
| Low | 2.1B | 2.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 24.5% | 21.4% |
| Avg | 9.6% | 5.5% |
| Low | 0.3% | -5.5% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.60 | 0.75 |
| Avg | 0.39 | 0.64 |
| Low | 0.20 | 0.55 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 91.7% |
| Avg | - | 64.9% |
| Low | - | 41.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.